Reasons to Engage with USC Stevens
Thriving Research Enterprise in a Vibrant Innovation Ecosystem
USC is one of the world’s leading private research universities with more than $909 million in annual research expenditures in 2019. The university is ideally situated in the heart of a diverse, vibrant, innovative region.
Solution Oriented, Win-Win Approach
We bring an innovative mindset to deepening and strengthening our relationships with industry partners and take a solution-oriented, win-win approach to our interactions.
Experienced, Insightful Team of Technology Licensing Pros
Our senior management team has extensive experience in both the private sector and academic/research institutions. They lead a talented team with broad expertise across a number of disciplines.
Featured Technologies
USC Researchers Develop Low-Cost Blood Test for Early Alzheimer’s Detection
Researchers from the Keck School of Medicine of USC have developed a blood test that can identify early signs of Alzheimer’s disease by measuring proteins linked to the condition. The new test, known as Penta-Plex
USC’s Groundbreaking Research Could Revolutionize Glioblastoma Treatment
The glioma subtype known as glioblastoma is notoriously difficult to treat. Current treatments for glioblastoma are unable to successfully address the heterogeneity between different glioblastoma tumors. The fact is that glioblastomas differ markedly between
USC Executes Exclusive License Agreement with Ellison Medical Institute for a Transformative Technology for Prostate Cancer Treatment
The University of Southern California (USC) is thrilled to announce that it has entered into an exclusive licensing agreement with the Ellison Medical Institute (EMI) for the rights to develop and commercialize a novel therapeutic
Success Stories
USC Researchers Develop Low-Cost Blood Test for Early Alzheimer’s Detection
Researchers from the Keck School of Medicine of USC have developed a blood test that can identify early signs of Alzheimer’s disease by measuring proteins linked to the condition. The new test, known as Penta-Plex
Nasdaq’s Opening Bell Rings for a USC Research Startup
Today, a USC-licensed startup that developed an intranasal drug delivery system for brain tumors will be listed for the first time on Nasdaq. To celebrate the direct listing, the USC Stevens Center for Innovation and
L-Nutra Closes $47 Million in First Stage of Growth Investment Round
Congratulations to Dr. Valter Longo, Director of the Longevity Institute at USC and his venture, L-Nutra Inc., a premier nutri-technology company leading longevity science nutrition programs, on the closure of a $47M Series D funding. The round